Study of circulating Th17 cells and associated cytokines in myasthenia gravis

Study of circulating Th17 cells and associated cytokines in myasthenia gravis

Objective To investigate the expression of helper T cell 17 (Th17) cells and associated cytokines in patients with myasthenia gravis (MG) and its correlations to the level of anti-acetylcholine receptor (AChR) antibodies. Methods Thirty patients with MG including 16 patients with ocular myasthenia g...

Full description

Bibliographic Details
Main Authors:	Yu-han GAO, Hai-qiang JIN, Hong-jun HAO, Yong-an SUN, Feng GAO
Format:	Article
Language:	English
Published:	Tianjin Huanhu Hospital 2019-10-01
Series:	Chinese Journal of Contemporary Neurology and Neurosurgery
Subjects:	myasthenia gravis t-lymphocytes interleukins reverse transcriptase polymerase chain reaction enzyme-linked immunosorbent assay
Online Access:	http://www.cjcnn.org/index.php/cjcnn/article/view/2036

Similar Items

Detection and clinical significance of serum autoantibodies in patients with myasthenia gravis
by: Yun LIU, et al.
Published: (2016-10-01)

Myasthenia gravis and acetylcholine receptor antibodies: A clinico immunological correlative study on South Indian patients
by: Bindu P, et al.
Published: (2008-01-01)

Myasthenia gravis and related disorders : 11th International Conference /
by: Kaminski, Henry J., et al.
Published: (2008)

Seronegative Maternal Ocular Myasthenia Gravis and Delayed Transient Neonatal Myasthenia Gravis
by: Courtney Townsel, et al.
Published: (2016-03-01)

Pregnancy with Myasthenia Gravis
by: Ninuk Dwi ariningtyas, et al.
Published: (2020-01-01)

Altered serum levels of cytokines in patients with myasthenia gravis
by: Shu-Li Wei, et al.
Published: (2024-01-01)

Fetal Surveillance in Pregnancies with Myasthenia Gravis
by: Brîndușa Ana Cimpoca-Raptis, et al.
Published: (2021-11-01)

Pediatric ocular myasthenia gravis: Case report and literature review
by: Adriana Solano, et al.
Published: (2019-01-01)

Disease severity assessment and short-term outcome in patients with myasthenia gravis
by: Deepthi Vemuri, et al.
Published: (2020-01-01)

The miracle of St. Alfege’s Hospital and the history of the treatment of myasthenia gravis
by: Cristina Croitoru, et al.
Published: (2017-03-01)

Myasthenia Gravis and Large Granular Lymphocytic Leukemia: a rare association
by: Yumeng Zhang, MD, et al.
Published: (2020-01-01)

Management of Juvenile Myasthenia Gravis
by: Karen O'Connell, et al.
Published: (2020-07-01)

Interleukin-27 levels in patients with myasthenia gravis
by: Liu Xiao-Jiao, et al.
Published: (2020-09-01)

Evidencia serológica de leptospirosis en pacientes con sospecha clínica de dengue en el estado de Ceará, Brasil
by: Laiane Fernanda de Melo Bezerra, et al.
Published: (2015-12-01)

Corticosteroid Treatment-Resistance in Myasthenia Gravis
by: Henry J. Kaminski, et al.
Published: (2022-04-01)

Thymectomy in 19 Cases of Myasthenia Gravis in 4 Years Follow up
by: Saeed Mahmoudi, et al.
Published: (2002-09-01)

Myasthenia gravis in children: analysis of 18 patients
by: Morita Maria da Penha A., et al.
Published: (2001-01-01)

Increased serum IL-36γ levels are associated with disease severity in myasthenia gravis patients
by: Qiu-Xia Zhang, et al.
Published: (2020-08-01)

Ocular myasthenia gravis and thymoma
by: Victor Alegre-Ituarte, et al.
Published: (2022-09-01)

Targeted treatment approaches and pathogenicity of antibody subclasses in MuSK-myasthenia gravis
by: Cao, M
Published: (2021)

Emerging Roles of Dysregulated MicroRNAs in Myasthenia Gravis
by: Lin Wang, et al.
Published: (2020-05-01)

Physiotherapy in myasthenia gravis
by: Klaudia Kwiatkowska, et al.
Published: (2018-12-01)

Physiotherapy in myasthenia gravis
by: Klaudia Kwiatkowska, et al.
Published: (2018-12-01)

Clinical characteristics of late-onset myasthenia gravis
by: Chenjing Sun, et al.
Published: (2024-04-01)

IL-4Rα Polymorphism Is Associated With Myasthenia Gravis in Chinese Han Population
by: Ping Jiang, et al.
Published: (2018-07-01)

Novel Immunotherapies for Myasthenia Gravis
by: Nair SS, et al.
Published: (2023-04-01)

Minimal Manifestation Status Indicates a Stable State in Myasthenia Gravis: A Quantitative Study
by: Ping Jiang, et al.
Published: (2022-05-01)

Failure of reversion of neuromuscular block with sugammadex in patient with myasthenia gravis: case report and brief review of literature
by: Hermann dos Santos Fernandes, et al.
Published: (2019-08-01)

Late-onset myasthenia gravis: Is it a different clinical entity?
by: Hulya Tireli, et al.
Published: (2021-01-01)

Posterior reversible encephalopathy syndrome following septicemia in patient with myasthenia gravis
by: Pham Dang Hai, MD, et al.
Published: (2023-04-01)

The Role of Osteopontin and Its Gene on Glucocorticoid Response in Myasthenia Gravis
by: Yanchen Xie, et al.
Published: (2017-05-01)

Generalized Myasthenia Gravis Diagnosed After Blepharoplasty
by: Murat Alemdar, et al.
Published: (2021-12-01)

PLASMAPHERESIS IN THE TREATMENT OF MYASTHENIA GRAVIS: OUTCOME AND COMPLICATIONS
by: Maryam Abbas, et al.
Published: (2021-04-01)

Sotalol‐induced generalized and ocular myasthenia gravis
by: Mohammadbagher Sharifkazemi, et al.
Published: (2019-09-01)

Effect of Thymectomy in Myasthenia Gravis
by: Tuncay Gündüz
Published: (2016-12-01)

MYASTHENIA GRAVIS, DIAGNOSIS AND TREATMENT
by: A.A Gde Agung Anom Arie W, et al.
Published: (2013-05-01)

Thymoma with Myasthenia Gravis in Adolescent
by: Prasad K Shetty,, et al.
Published: (2011-01-01)

Editorial: Phenotypes of myasthenia gravis, volume II
by: Hai-Feng Li, et al.
Published: (2023-11-01)

Национален консенсус за диагностика и лечение на myasthenia gravis
by: Ivan Milanov, et al.
Published: (2021-03-01)

Национален консенсус за диагностика и лечение на myasthenia gravis
by: Ivan Milanov, et al.
Published: (2023-04-01)